Advertisement
Screener

AARDVARK THERAPEUTICS, INC. (AARD) Patents: Active

AARDVARK THERAPEUTICS, INC. Active Patents

4 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-08-01: Application 18363328; Invention ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER; Applicant Aardvark Therapeutics, Inc.; Status Patented Case.
  • 2023-06-23: Application 18340308; Invention ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER; Applicant Aardvark Therapeutics, Inc.; Status Patented Case.
  • 2022-09-29: Application 17915952; Invention Method for Treating SARS and Treating or Preventing ARDS; Applicant AARDVARK THERAPEUTICS, INC.; Status Patented Case.
  • 2020-12-27: Application 17256212; Invention Oral Pharmaceutical Formulations of Bitter Compounds for Asthma; Applicant Aardvark Therapeutics Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-08-0118363328ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCERAardvark Therapeutics, Inc.Patented Case2025-06-1712329739US20230372287A1
George JEOFFREYS
Alison JOHNSON
Andrew HEATON
Ofir MORENO
Australia
Australia
Australia
United States
NEAGU, IRINA
2023-06-2318340308ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCERAardvark Therapeutics, Inc.Patented Case2025-06-0312318364US20240165073A1
Ofir MORENO
United States
NEAGU, IRINA
2022-09-2917915952Method for Treating SARS and Treating or Preventing ARDSAARDVARK THERAPEUTICS, INC.Patented Case2025-09-3012427125US20230149328A1
Tien-Li LEE
United States
ROSENTHAL, ANDREW S
2020-12-2717256212Oral Pharmaceutical Formulations of Bitter Compounds for AsthmaAardvark Therapeutics Inc.Patented Case2025-01-2112201593US20210161838A1
Tien-Li Lee
Zhenhuan Zheng
United States
United States
RAMACHANDRAN, UMAMAHESWARI

Similar stocks

Stock NameCountryMarket CapPE Ratio
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31